Vir Biotechnology, Inc.·4

Feb 21, 7:24 PM ET

Pang Phillip 4

4 · Vir Biotechnology, Inc. · Filed Feb 21, 2023

Insider Transaction Report

Form 4
Period: 2023-02-17
Pang Phillip
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2023-02-17$25.29/sh2,802$70,857141,198 total
Footnotes (1)
  • [F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION